Results 191 to 200 of about 1,442,499 (293)

Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort

open access: yesVIEW, EarlyView.
Probiotic supplements have shown benefits in reducing all‐cause mortality among hospitalized patients with SARS‐CoV‐2 infection. Patients with severe illness or without antiviral treatment were more likely to use probiotic supplements. Probiotic supplements may be a promising adjunctive therapy for SARS‐CoV‐2 infection.
Mengzhao Yang   +14 more
wiley   +1 more source

He was only thirty one. [PDF]

open access: yesPalliat Support Care
Shapoo N, Boma N.
europepmc   +1 more source

ON THE BRIGHTER SIDE OF THE NIGHT: Discovering Community and Care in Night Shift Work

open access: yesInternational Journal of Urban and Regional Research, EarlyView.
Abstract Within the burgeoning attention being paid to the night‐time economy (NTE) in and by cities, the demands and impacts of night work have gathered increasingly scholarly attention. Research has centred on the darker side of these, pointing to workers' precarity and vulnerability. What if we attend also to a ‘brighter side’ of the night and night
Jesse Mentha   +3 more
wiley   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel   +5 more
wiley   +1 more source

Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate‐to‐Severe Endometriosis Pain: A Phase III, Multicentric, Double‐Blind, Active‐Controlled, Non‐Inferiority Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To compare the efficacy, safety and tolerability of elagolix with dienogest in women with moderate‐to‐severe endometriosis‐associated pain. Design A multicentre, double‐blind, double‐dummy, randomised, parallel‐group, active‐controlled, non‐inferiority phase III study. Setting Nineteen clinical centres across India.
Sneha Bhoir   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy